PRLHR Immune Genes Associated With Tumor Mutation Burden can be Used as Prognostic Markers in Patients With Gliomas

PRLHR Immune Genes Associated With Tumor Mutation Burden can be Used as Prognostic Markers in Patients With Gliomas

Tumor mutation burden (TMB) is a useful biomarker for predicting the prognosis and efficacy of immune checkpoint inhibitor (ICIs). In this study, we aimed to explore the prognostic value of TMB and TMB-related PRLHR immune genes as prognostic markers in patients with gliomas. We downloaded MAF files...

Full description

Bibliographic Details
Main Authors:	Yi Liu, Juan Xiang, Gang Peng, Chenfu Shen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Oncology
Subjects:	RPLHR CIBERSORT TMB prognosis glioma
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.620190/full

Similar Items

Immune-Related Genes to Construct a Novel Prognostic Model of Breast Cancer: A Chemosensitivity-Based Study
by: Zhi-Min Deng, et al.
Published: (2021-10-01)

Identification of tryptophan metabolic gene-related subtypes, development of prognostic models, and characterization of tumor microenvironment infiltration in gliomas
by: Yi Liu, et al.
Published: (2022-11-01)

The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas
by: Yueyang Ba, et al.
Published: (2022-06-01)

The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer
by: Yaxiong Zhang, et al.
Published: (2019-04-01)

CircRNA NALCN acts as an miR-493-3p sponge to regulate PTEN expression and inhibit glioma progression
by: Yi Liu, et al.
Published: (2021-06-01)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
by: Wen Yin, et al.
Published: (2020-08-01)

Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort
by: Yi Liu, et al.
Published: (2021-11-01)

GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer
by: Yan Yang, et al.
Published: (2021-07-01)

The Landscape of the Tumor-Infiltrating Immune Cell and Prognostic Nomogram in Colorectal Cancer
by: Jiateng Zhong, et al.
Published: (2022-05-01)

Construction and Validation of an Immune-Related Prognostic Model Based on TP53 Status in Colorectal Cancer
by: Xiaojuan Zhao, et al.
Published: (2019-11-01)

Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers
by: Timothy V. Pham, et al.
Published: (2021-10-01)

Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study
by: Giuseppe Lombardi, et al.
Published: (2020-08-01)

Expression and Prognostic Role of Glia Maturation Factor-γ in Gliomas
by: Junhui Liu, et al.
Published: (2022-06-01)

DNA methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden
by: Hao Huang, et al.
Published: (2023-01-01)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
by: Chunguang Guo, et al.
Published: (2022-03-01)

CDH6 as a prognostic indicator and marker for chemotherapy in gliomas
by: Ming Meng, et al.
Published: (2022-07-01)

UTRN as a potential biomarker in breast cancer: a comprehensive bioinformatics and in vitro study
by: Han Li, et al.
Published: (2024-04-01)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
by: Hua Zhu, et al.
Published: (2021-09-01)

A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients
by: Zijin Xiang, et al.
Published: (2021-08-01)

Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma
by: Zesheng Peng, et al.
Published: (2023-04-01)

Predictive Value of Preoperative Hematologic Inflammatory Markers in Prognostic of Glioma Patients
by: YU Xuedi, et al.
Published: (2019-08-01)

Computational immune infiltration analysis of pediatric high‐grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location
by: Cavan P. Bailey, et al.
Published: (2021-09-01)

The prognostic value of tumor mutational burden related 6-gene-based Risk Score in laryngeal cancer patients
by: Dong Yang, et al.
Published: (2022-11-01)

mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers
by: Lei Cheng, et al.
Published: (2022-05-01)

Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma
by: Cunte Chen, et al.
Published: (2021-03-01)

Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma
by: Chengde Wu, et al.
Published: (2021-02-01)

Combined ARHGEF6 and Tumor Mutational Burden may serve as a potential biomarker for immunotherapy of lung adenocarcinoma
by: Li Tong, et al.
Published: (2023-08-01)

The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?
by: Zhuang Liu, et al.
Published: (2021-10-01)

Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
by: Wenjie Li, et al.
Published: (2022-02-01)

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
by: Xin Cheng, et al.
Published: (2021-02-01)

MHC-I genotype and tumor mutational burden predict response to immunotherapy
by: Aaron M. Goodman, et al.
Published: (2020-05-01)

A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma
by: Xiaomin Cai, et al.
Published: (2021-02-01)

A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy
by: Hui Zhou, et al.
Published: (2023-01-01)

Clinical Significance and Prognostic Value of Human Soluble Resistance-Related Calcium-Binding Protein: A Pan-Cancer Analysis
by: Jinguo Zhang, et al.
Published: (2021-11-01)

The copper-associated protein STEAP2 correlated with glioma prognosis and immune infiltration
by: Xu Wang, et al.
Published: (2022-08-01)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
by: Kai Xiao, et al.
Published: (2020-01-01)

BCL7A as a novel prognostic biomarker for glioma patients
by: Junhui Liu, et al.
Published: (2021-08-01)

Hub gene identification and prognostic model construction for isocitrate dehydrogenase mutation in glioma
by: Yanfei Jia, et al.
Published: (2021-01-01)

Prognostic RNA-editing signature predicts immune functions and therapy responses in gliomas
by: Yi He, et al.
Published: (2023-02-01)

The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients
by: Shengjin Cui, et al.
Published: (2023-02-01)